Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: ChemTrak

This article was originally published in The Gray Sheet

Executive Summary

ChemTrak: Submits premarket approval application to FDA for its home HIV test kit, making it the second firm, along with J&J subsidiary Direct Access Diagnostics, to seek agency approval for such a product. The ChemTrak test involves pricking the finger with a lancet, placing two drops of blood on a special paper, and then sending the sample in a postage-paid mailer to ChemTrak for testing. The product was obtained by ChemTrak through the acquisition of Coonan Clinical Labs ("The Gray Sheet" Jan. 2, p. 5), which was completed on Feb. 3...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts